33 results about "Renal patient" patented technology

A system and a method for tracking patients having renal disease, particularly Chronic Kidney Disease (CKD), are provided. The system and method track patients through a common system with multiple healthcare professionals, such as doctors, nurses and the like, having access to the system and updating the system based on information regarding the care, treatment, diagnosis, therapy, or the like provided to the patients. The system and method interface with remote machines and supply chains by a modem, via the internet or by wireless devices. The system and method provide a continuum of care for renal patients, i.e., CKD, peritoneal dialysis (PD), home hemodialyis (HHD), in-center hemodialysis and transplant within a single database associated with the system. The system and method track the access information of PD patients and / or HD patients. Specifically, the system and method track access placement, infections, non-infection related problems, medications and hospitalizations. The system and method may track PD and HD information in one comprehensive module.

The present invention relates to novel methods for monitoring and guiding therapeutic suppression of parathyroid hormone in renal patients having secondary hyperparathyroidism. One determines and monitors the level of parathyroid hormone agonist and parathyroid hormone antagonist in the renal patient. The parathyroid hormone suppressing therapeutic is administered to the patient so as to minimize the level of parathyroid hormone antagonist.

The present invention relates to compositions and methods for treating the nutritional deficiencies observed in patients suffering from renal disease and associated disorders. Specifically, the method involves administering to a renal patient a composition comprising vitamin C, vitamin E, the B-complex vitamins, chromium, selenium, and zinc.

The present invention relates to compositions and methods for treating the nutritional deficiencies observed in patients suffering from renal disease and associated disorders. Specifically, the method involves administering to a renal patient a composition comprising vitamin C, vitamin E, B-complex vitamins, selenium, and zinc.

The invention discloses a composition for patients with chronic renal disease and preparing method thereof, and belongs to the technical field of medical food. The composition is prepared from, 33.4-58.6 g / l of protein, 62.5-123 g / l of fat, 204-305 g / l of carbohydrates, 5.0-20 g / l of dietary fiber, 0.14-0.68 g / l of phosphorus, 0.2-1.68 g / l of sodium, 0.2-2.00 g / l of potassium, 0.3-1.33 g / l of calcium, 0.04-0.30 g / l of magnesium, 1.0-2.25 mg RE / L of vitamin A, 4.6-8.6 mg RE / L of vitamin B complex, microelement, other vitamins, and water. The invention matches scientifically, and has high heat,low phosphorus ,sodium and potassium.The content of vitamin A is low while the content of vitamin B is high, conforming to the principle of nutrition support. The composition is easy to digest and is the main nutrient source of patients with chronic renal disease.

A use includes initiating a blood fluid removal session of a patient; monitoring an indicator of tissue fluid volume of the patient, or a portion thereof, during the blood fluid removal session; monitoring an indicator of blood fluid volume of the patient during the blood fluid removal session; determining whether a ratio of the indicator of tissue fluid volume to indicator of blood fluid volume is outside of a predetermined range; and altering the rate of fluid removal during the blood fluid removal session if the ratio is determined to be outside of the predetermined range. A blood fluid removal system may be configured to carry out the use.

The invention provides a platform convenient for doctor management and patient self-supervision, and aims to assist a patient to know a health condition and remind the patient to timely go back to a hospital for follow-up visit. The platform has main functions of patient archiving, examination index input, follow-up visit plan and rehabilitation plan pushing and reminding, related follow-up visit data analysis and the like, and provides online expert consultation and wardmate communication, thereby facilitating self-management and self-supervision of the patient. While follow-up visit and diagnosis and treatment process management is covered, data accumulated in an operation process is subjected to statistical analysis, so that big data value is comprehensively reflected and powerful data support and decision support are provided for clinic scientific and research of nephrology departments. The follow-up visit is taken as a center; for the patient with the chronic kidney disease, the follow-up visit is performed in the way; the problem that a kidney disease assistant in China at present takes no count of the follow-up visit is solved; the burden of a doctor and the frequency of going to the hospital for the patient are reduced; and a few unnecessary expenses are saved.

The invention provides methods for treatment of bacterial infections in impaired renal patients. Methods of the invention include administration of a therapeutically effective dose of dalbavancin for treatment of a bacterial infection, in particular a Gram-positive bacterial infection of skin and soft tissue.

The invention discloses a marker for detecting early diabetic nephropathy and an application methodof the marker. The application method includes the steps that a TTP is used as the diagnostic markerof diabetic nephropathy, TTP expression levels in blood and urine samples of a diabetic nephropathy patient are detected to be compared with normal values of a TTP expression level, and the illness state is diagnosed after difference analysis of the TTP expression level. According to the application method, early diabetic patients without clinical proteinuria but with actually developed diabetic kidney injury can be found, the diagnosis rate of early diabetic nephropathy is increased, and a basis for diagnosis of diabetic nephropathy is provided; and compared with traditional use of clinical symptoms, the advantage of early diagnosis is achieved, and compared with kidney puncture biopsy, the advantage of noninvasive diagnosis is achieved.

The invention provides methods and compositions for treatment of bacterial infections. The composition may be a combination of factors, which include A0, A1, B1, B2, C0, C1, isoB0, and MAG, in the presence of low level solvent. Methods of the invention include administration of dalbavancin formulations for treatment of a bacterial infection, in particular a Gram-positive bacterial infection of skin and soft tissue. Dosing regimens include multiple dose administration of dalbavancin, which often remains at therapeutic levels in the bloodstream for at least one week, providing prolonged therapeutic action against a bacterial infection. Dosing regimens for renal patients are also included.

The invention discloses low-protein noodles and a making method thereof. The low-protein noodles comprise raw materials of 0-30 parts of wheat flour, 30-100 parts of edible starch, 0-30 parts of modified starch, 0-15 parts of konjac powder, 0.1-0.4 part of propylene glycol alginate, 0.1-0.3 part of sodium carbonate, 0.1-0.2 part of sodium polyacrylate, 0.05-0.08 part of sodium pyrophosphate, 0.02-0.05 part of sodium tripolyphosphate and 0.1-0.3 part of calcium carbonate. The protein content of the low-protein noodles is lower than 3g / 100g, based on the condition that patients suffering from achronic kidney disease take in 300 g of the low-protein noodles every day, enough calorie is guaranteed, besides, the intake of non-superior protein every day is smaller than 9g, enough space is provided for the intake of high-quality protein, and the nutrition structure of the patients suffering from the chronic kidney disease is comprehensively balanced. Besides, the low-protein noodles are similar to ordinary noodles in mouth feel, so that the compliance of the patients is greatly improved, the patients can insist on eating the low-protein noodles for a long term easily, and the low-proteinnoodles are an ideal staple food for the patients suffering from the chronic kidney disease.

The invention is a method of detecting CAD in a CKD diagnosed human patient or CKD in a diagnosed CAD patient, or detection the presence of both CDK and CAD by assaying a plasma or serum sample of a human patient for elevated levels of BMP-4.

A use includes monitoring an indicator of fluid volume of a patient via a sensor device, and setting an initial fluid volume removal prescription for a blood fluid removal session based on the monitored indicator of fluid volume. The use may further include transmitting data regarding the indicator of fluid volume from the implantable sensor device to fluid removal device. In some embodiments, the fluid removal device sets or calculated the initial fluid volume removal prescription based on the data received from the implantable sensor. The indicator of fluid volume may be an indicator of tissue fluid volume or an indicator of blood fluid volume.

The present invention relates to compositions and methods for treating the nutritional deficiencies observed in patients suffering from renal disease and associated disorders. Specifically, the method involves administering to a renal patient a composition comprising vitamin C, vitamin E, B-complex vitamins, selenium, and zinc.

The invention relates to a medicine for treating chronic kidney diseases and in particular relates to a medicine for treating blood-heat and damp-heat uremia of a chronic kidney disease. The medicine can be used for solving the problems that the curative effect of treating the chronic kidney disease is unsatisfying, the side effect is unpredictable and long-course treatment is inapplicable. The medicine is prepared from the following components: ramulus euonymi general flavones, oldenlandia diffusa polysaccharide and yam total saponins in a weight ratio of 3:1:3, as well as pharmaceutic adjuvant. The compatibility of the medicine disclosed by the invention not only satisfies the conventional theory of traditional Chinese medicine, but also reflects the pharmacological research result of the modern Chinese medicine. The medicine has a good therapeutic effect to a patient with blood-heat and damp-heat uremia of chronic kidney diseases at stage I and stage II, and can be used for effectively strengthening the immune function of the body, relieving the hypercoagulable state of the blood of a patient with kidney disease, and restoring and improving the filtration barrier of the glomerulus, thereby achieving the purpose of removing proteinuria and improving the kidney function.

The invention discloses a lifting and decompressing device for scrotal edema of a kidney disease patient, and relates to the technical field of kidney disease patient maintenance. The lifting and decompressing device comprises a binding waistband and a second connecting band, wherein mounting blocks are mounted on the two corresponding sides of the binding waistband; inner mounting grooves are formed in the two mounting blocks; locking gears are rotatably connected to the interiors of the inner mounting grooves; and wire harness winding discs are mounted on one sides of the locking gears. Thelifting and decompressing device for scrotal edema of the kidney disease patient has the beneficial effects that by using a lifting device with a locking structure, the scrotum can be wrapped with a lower pocket belt; the penis is sleeved with a first connecting belt and a second connecting belt; the scrotum is lifted through the connecting wire harness, so that the pressure of testicles on the scrotum can be effectively reduced; and meanwhile, the lifting height of the lower pocket belt can be adjusted through the locking structure capable of rotating in one direction, so that the device canbe better suitable for being used by different patients, and the applicability of the patients is improved.

An object of the present invention is to provide a pharmaceutical agent which is administered to a patient with chronic kidney disease in which the progress of worsening of renal function is rapid whereby the progress of the symptom is suppressed or improved.The present invention relates to a progress-suppressing or improving agent for chronic kidney disease containing 5-hydroxy-1-methylhydantoin as an active ingredient. The pharmaceutical agent of the present invention showed a significant effect in a patient with chronic kidney disease where progress of the renal function decrease is rapid. The present pharmaceutical agent is very useful as a highly safe pharmaceutical agent which suppresses or improves the progress of worsening of the renal function of a patient with rapidly progressive chronic kidney disease for which there has been no effective therapeutic agent being simply and easily ingestible.

The invention discloses a food composition suitable for patients with chronic kidney diseases to eat. The invention is characterized in that the food composition suitable for the patients with the chronic kidney diseases to eat is prepared from the following ingredients in parts by weight: lotus root starch, sweet potato flour, wheat starch, corn starch, millets, black rice, coix seeds, adzuki beans, Chinese yams, euryale ferox seeds, konjac, chestnut kernels, black sesame seeds, fermented black soybeans, shiitake mushrooms, mulberry fruits, walnut kernels, Chinese wolfberry fruits, red dates, raisins, wheat germs, kudzu-vine root powder, hawthorn fruit powder, tomato powder, carrot powder, concentrated whey protein, olive oil, perilla frutescens oil, corn oil, maltodextrin, L-carnitine, L-malic acid and calcium acetate. The invention further discloses a preparation method of the food composition suitable for the patients with the chronic kidney diseases to eat. The food composition provided by the invention is balanced in nutrition, and is suitable for dietary requirements of the patients with the chronic kidney diseases; moreover, the food composition also has the functions of regulating the important human organs, including the liver, the spleen, the stomach and so on.

Methods and apparatus for predicting / estimating the dry weight of an individual, e.g., a patient undergoing dialysis treatment, are provided. The techniques employ a bioimpedance measurement (303) on the individual's calf (101) to obtain information regarding the extracellular fluid volume of the calf. Using a measurement of the calf's circumference (309), a resistivity value is calculated, normalized by the individual's body mass index (BMI), and then offset by a reference value to obtain a new variable, nRho, which is shown, by comparison with a "gold standard" (FIGS. 5-9), to be highly effective in predicting / estimating dry weight (FIGS. 10-13 and 15-16). The techniques are easy to use and provide accurate dry weight predictions / estimations without substantially adding to the complexity or cost of dialysis procedures.; The techniques can also be used for individuals who are not renal patients, e.g., patients suffering from other diseases in which fluid overload can occur, athletes, fitness enthusiasts, and the like.

The invention relates to the technical field of drinking water filtering, and discloses a filtering device for drinking water of patients in the nephrology department. The filtering device comprises a machine body, wherein a purifying and filtering structure is arranged in the machine body and located at the inner upper end of the machine body, a disinfection treatment structure is arranged in the machine body and located at the inner lower end of the machine body, and a water outlet structure is arranged in the machine body and located on one side of the disinfection treatment structure. Heavy metal elements in the drinking water are removed and the water is softened through the purifying and filtering structure; the drinking water is disinfected through the disinfection treatment structure so as to remove microorganisms in the drinking water; and the treated drinking water is temporarily stored and discharged through the water outlet structure; and thus, when a patient with kidney diseases drinks the treated water, the the burden of the kidney of the patient is reduced, the treatment of the patient is ensured, and the aggravation of the illness of the patient is avoided.

The invention provides a postoperative nursing device for kidney disease patients, and belongs to the technical field of medical auxiliary equipment. According to the technical scheme, the urine bag comprises a urine bag body, a liquid inlet and an exhaust port are formed in the upper end of the urine bag body, the guide pipe is inserted into the urine bag body, the lower end of the guide pipe is located on the upper portion of the urine bag body, and the upper end of the guide pipe extends out of the urine bag body; a floater is arranged in the guide pipe, a guide rod is arranged at the upper end of the floater and extends out of the guide pipe, and an annular baffle for preventing the floater from sliding off is arranged at one end, located in the urine bag, of the guide pipe; the device further comprises a limiting ring, the urine bag is arranged in the limiting ring, a protective cover made of non-transparent materials is arranged on the outer side of the limiting ring and comprises an outer baffle and side baffles arranged on the two sides of the outer baffle, and the two side baffles are arranged on the outer wall of the limiting ring. And the warning structure can be driven by the guide rod. The urine bag shielding device has the advantages that the urine bag of a kidney disease patient needing to urinate with the help of the catheter is properly shielded.

The invention discloses honey pomelo lollipop, prepared from the following raw materials in parts by weight: 16 to 24 parts of Guanxi honey pomelo, 10 to 16 parts of fresh fruit juice, 20 to 25 parts of water, 4 to 8 parts of honey, 1 to 3 parts of hydroxymethyl cellulose, 0.5 to 2.5 parts of citric acid, 0.3 to 1.3 parts of ascorbic acid, 5 to 9 parts of maltose, 3 to 10 parts of high fructose corn syrup, 8 to 16 parts of liquorice root, 6 to 12 parts of loquat juice and 3 to 5 parts of herba menthae. The honey pomelo lollipop is good for patients with cardia-cerebrovascular diseases and kidney diseases to eat, contains a large amount of vitamin C and can reduce cholesterol in blood; meanwhile, fresh fruit juice prepared from various fresh fruits is added, so that the honey pomelo lollipop contains various vitamins, the nutritional value is increased, meanwhile, the taste is improved, and in addition, liquorice and loquat juice are also added, so that the honey pomelo lollipop has a good taste. In addition, by utilizing the cough-relieving and lung-moistening effects of the loquat juice and the liquorice, the honey pomelo lollipop has the effects of relieving cough and moistening lung.

An object of the present invention is to provide a pharmaceutical agent which is administered to a patient with chronic kidney disease in which the progress of worsening of renal function is rapid whereby the progress of the symptom is suppressed or improved.The present invention relates to a progress-suppressing or improving agent for chronic kidney disease containing 5-hydroxy-1-methylhydantoin as an active ingredient. The pharmaceutical agent of the present invention showed a significant effect in a patient with chronic kidney disease where progress of the renal function decrease is rapid. The present pharmaceutical agent is very useful as a highly safe pharmaceutical agent which suppresses or improves the progress of worsening of the renal function of a patient with rapidly progressive chronic kidney disease for which there has been no effective therapeutic agent being simply and easily ingestible.

The present invention discloses a method for prognosing and reducing cardiovascular diseases in patients with kidney diseases, comprising obtaining a bio-sample of a healthy person and a bio-sample of a patient with kidney disease, detecting the expression of specific lncRNA biomarkers individually, such as one or more combinations of DKFZP434I0714, KCNJ2AS1, LOC256880, LOC644656, FAM86FP, FAM66D, LOC100289511, and HTR7P1, comparing the expressions between the samples of the healthy persons and the samples of the patients with kidney diseases to obtain a ratio, and prognosing whether the patients with kidney diseases belong to a high-risk group to have cardiovascular diseases based on the ratio. Furthermore, the method reduces the possibility of patients with kidney diseases to have cardiovascular diseases through the inhibition technology.

The invention relates to the technical field of drinking water filtration, and discloses a drinking water filtering device for nephrology patients. Including the body, the body is provided with a purification and filtration structure, the purification and filtration structure is located at the upper end of the body, the body is provided with a disinfection treatment structure, the disinfection treatment structure is located at the lower end of the body, and the body is provided with a water outlet structure, and the water outlet structure is located at the disinfection treatment structure side. Remove the heavy metal elements in drinking water and soften the water quality through the purification and filtration structure, disinfect the drinking water through the disinfection treatment structure to remove microorganisms in the drinking water, and temporarily store and release the treated drinking water through the water outlet structure, so that the kidneys When sick patients drink the treated water, the burden on their kidneys is reduced to ensure the treatment of the patients and avoid the aggravation of the patients' condition.

The invention discloses a traditional Chinese medicinal composition for reducing a urinary protein content in a patient with chronic renal disease. The traditional Chinese medicinal composition consists of the following components in parts by weight: 7-9 parts of cordyceps sobolifera, 10-12 parts of mushrooms, 8-10 parts of rhizoma dioscoreae, 8-10 parts of honeysuckle flowers, 8-10 parts of coix seeds, 5-7 parts of radix astragali, 3-5 parts of maca, 8-10 parts of moringa oleifera leaves, 3-5 parts of fructus hordei germinatus, 3-5 parts of radix puerariae, 4-6 parts of eucommia bark, 4-6 parts of radix notoginseng, 3-5 parts of black sesames, 8-10 parts of black fungi, 10-12 parts of saussurea involucrata fruits and 5-7 parts of walnut kernels. The traditional Chinese medicinal composition disclosed by the invention has functions of tonifying kidney and qi and clearing away heat and toxic materials; the traditional Chinese medicinal composition is capable of reducing the urinary protein content in the patient with the chronic renal disease and protecting renal function; and the traditional Chinese medicinal composition, which is safe and free from toxic and side effects, can be taken for a long time.